Considering consumer choice in the economic evaluation of mandatory health programmes: A review

Health Policy

Volumn 101, Issue 3, 2011, Pages 236-244

  Parkinson, Bonny ^a   Goodall, Stephen ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Consumer choice; Cost benefit analysis; Economics; Mandatory programs; Public opinion

Indexed keywords

ADVERSE OUTCOME; CONSUMER ADVOCACY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; INCOME; MANDATORY PROGRAM; PRODUCTIVITY; REVIEW;

COST-BENEFIT ANALYSIS; EVALUATION STUDIES AS TOPIC; HEALTH CARE COSTS; HUMANS; MANDATORY PROGRAMS; PATIENT COMPLIANCE; PATIENT PREFERENCE;

EID: 79960109960     PISSN: 01688510     EISSN: 18726054     Source Type: Journal    
DOI: 10.1016/j.healthpol.2010.09.007     Document Type: Review

References (65)

1. Oakley G., Johnston R. Balancing benefits and harms in public health prevention programmes mandated by governments. BMJ 2004, 329:41-43.
2. Segal L., Dalziel K., Katz R. Informing a strategy for increasing folate levels to prevent neural tube defects: a cost-effectiveness analysis of options: a report for Food Standards Australia and New Zealand, Monash University and University of South Australia, Editor 2007, Food Standards Australia and New Zealand.
3. Access Economics Cost benefit analysis of fortifying the food supply with iodine: Report for Food Standards Australia and New Zealand 2006, Access Economics, Canberra.
4. Goodall S., Norman R.P., Gallego G. Cost-effectiveness analysis of alternate strategies to address iodine deficiency in Australia, CHERE Project Report for the Department of Health and Ageing, Australian Government 2007, CHERE, Sydney, p. 1-99.
5. Coughlin S. Ethical issues in epidemiologic research and public health practice. Emerging Themes in Epidemiology 2006, 3:16.
6. Sadique M. Individual freedom versus collective responsibility: an economic epidemiology perspective. Emerging Themes in Epidemiology 2006, 3:12.
7. Grosse S., et al. Reevaluating the benefits of folic acid fortification in the United States: economic analysis, regulation, and public health. American Journal of Public Health 2005, 95(11):1917-1922.
8. Bentley T.G., et al. A cost-effectiveness analysis of folic acid fortification policy in the United States. Public Health Nutrition 2009, 12(4):455-467.
9. Davies G.N. Fluoride in the prevention of dental caries: a tentative cost-benefit analysis. British Dental Journal 1973, 135(4):173-174.
10. Demicheli V., Jefferson T.O. Cost-benefit analysis of the introduction of mass vaccination against hepatitis B in Italy. Journal of Public Health Medicine 1992, 14(4):367-375.
11. Doessel D.P. Cost-benefit analysis of water fluoridation in Townsville, Australia. Community Dentistry and Oral Epidemiology 1985, 13(1):19-22.
12. Downer M., Blinkhorn A., Attwood D. Effect of fluoridation on the cost of dental treatment among urban Scottish schoolchildren. Community Dentistry and Oral Epidemiology 1981, 9(3):112-116.
13. Ginsberg G., Silverberg D. A cost-benefit analysis of legislation for bicycle safety helmets in Israel. American Journal of Public Health 1994, 84(4):653-656.
14. Griffin S., Jones K., Tomar S. An economic evaluation of community water fluoridation. Journal of Public Health Dentistry 2001, 61(2):78-86.
15. Grosse S, et al. The costs and benefits of folic acid fortification in the United States: a comparison of ex ante and ex post economic evaluations, in Department of Economics Working Paper Series, Working Paper No: 2004-08. University of Utah, Salt Lake City, US; 2004.
16. Hansen P, Scuffham P.A. The cost-effectiveness of compulsory bicycle helmets in New Zealand. Australian Journal of Public Health 1995, 19(5):450-454.
17. Hatziandreu E., et al. The cost effectiveness of three programs to increase use of bicycle helmets among children. Public Health Reports 1995, 110(3):251.
18. Hertrampf E., Cortes F. National food-fortification program with folic acid in Chile. Food and Nutrition Bulletin 2008, 29(2 Suppl.):S231-S237.
19. Jentink J., et al. Economic evaluation of folic acid food fortification in the Netherlands. European Journal of Public Health 2008, 18(3):270-274.
20. Kopjar B., Wickizer T. Age gradient in the cost-effectiveness of bicycle helmets. Preventative Medicine 2000, 30:401-406.
21. Kowash M.B., Toumba K.J., Curzon M.E. Cost-effectiveness of a long-term dental health education program for the prevention of early childhood caries. European Archives of Paediatric Dentistry 2006, 7(3):130-135.
22. Llanos A., et al. Cost-effectiveness of a folic acid fortification program in Chile. Health Policy 2007, 83(2-3):295-303.
23. O'Connell J., et al. Costs and savings associated with community water fluoridation programs in Colorado. Preventing Chronic Disease: Public Health Research, Practice and Policy 2005, 2:1-13.
24. Ong M., Glantz S. Free nicotine replacement therapy programs vs. implementing smoke-free workplaces: a cost-effectiveness comparison. American Journal of Public Health and the Nations Health 2005, 95(6):969-975.
25. Romano P.S., et al. Folic acid fortification of grain: an economic analysis. American Journal of Public Health 1995, 85(5):667-676.
26. Sayed A., et al. Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. Birth Defects Research 2008, 82(4 (April)):211-216.
27. Thiry N., et al. An economic evaluation of varicella vaccination in Italian adolescents. Vaccine 2004, 22:3546-3562.
28. Taylor M., Scuffham P. New Zealand bicycle helmet law-Do the costs outweigh the benefits?. Injury Prevention 2002, 8:317-320.
29. van Wyk P., Kroon J., Holtshousen W. Cost evaluation for the implementation of water fluoridation in Gauteng. SADJ 2001, 56(2):71-76.
30. Wright J., et al. The cost-effectiveness of fluoridating water supplies in New Zealand. Australian New Zealand Journal of Public Health 2001, 25(2):170-178.
31. Dixon S., Shackley P. Estimating the benefits of community water fluoridation using the willingness-to-pay technique: results of a pilot study. Community of Dentistry and Oral Epidemiology 1999, 27:124-129.
32. Dixon S., Shackley P. The use of willingness to pay to assess public preferences towards the fortification of foodstuffs with folic acid. Health Expectations 2003, 6:140-148.
33. Shackley P., Dixon S. Using contingent valuation to elicit public preferences for water fluoridation. Applied Economics 2000, 32:777-787.
34. Manau C., et al. Economic evaluation of community programs for the prevention of dental caries in Catalonia. Spain. Community Dentistry and Oral Epidemiology 1987, 15(6):297-300.
35. Ranson M., et al. Global and regional estimates of the effectiveness and cost-effectiveness of price increases and other tobacco control policies. Nicotine and Tobacco Research 2002, 4(3):311-319.
36. Dalziel K., Segal L., Katz R. Cost-effectiveness of mandatory folate fortification v. other options for the prevention of neural tube defects: results from Australia and New Zealand. Public Health Nutrition 2010, 13(4):566-578.
37. Department of Health Smoke free workplaces and public places: economic analysis 2005, U.K. Department of Health.
38. Carr S.M., Dooland M.B., Roder D.M. Fluoridation II: an interim economic analysis. Australian Dental Journal 1980, 25(6):343-348.
39. Dowell T.B. The economics of fluoridation. British Dental Journal 1976, 140(3):103-106.
40. Niessen L.C., Douglass C.W. Theoretical considerations in applying benefit-cost and cost-effectiveness analyses to preventive dental programs. Journal of Public Health Dentistry 1984, 44(4):156-168.
41. Nelson W., Swint J.M. Cost-benefit analysis of fluoridation in Houston, Texas. Journal of Public Health Dentistry 1976, 36(2):88-95.
42. Ast D., et al. Time and cost factors to provide regular, periodic dental care for children in a fluoridated and non-fluoridated area: progress report II. American Journal of Public Health 1967, 57(9):1635-1642.
43. Ast D., et al. Time and cost factors to provide regular, periodic dental care for children in a fluoridated and nonfluoridated area: final report. Journal of American Dental Association 1970, 80:770.
44. Horowitz H., Heifetz S. Methods for assessing the cost-effectiveness of caries preventative agents and procedures. International Dental Journal 1979, 29(2):106-117.
45. Birch S. The relative cost-effectiveness of water fluoridation across communities: analysis of variations according to the underlying caries levels. Community Dental Health 1990, 7:3-10.
46. Kelly A., et al. Worked example: cost-effectiveness of strategies to prevent neural tube defects. Cost-effectiveness in health and medicine 1996, 313-348. Oxford University Press, New York. M. Gold (Ed.).
47. Mas-Colell A., Whinston M., Green J. Microeconomic theory 1995, Oxford University Press.
48. Aldous J. Annual public health report 2004 2004, Hillingdon Primary Care Trust, p. 33-40.
49. Donaldson C., Mason H., Shackley P. Contingent valuation in health care. The Elgar companion to health economics 2006, 392-402. Edward Elgar Publishing Limited, Cheltenham. A. Jones (Ed.).
50. Drummond M., et al. Cost-benefit analysis. Methods for the economic evaluation of health care programmes 2005, Oxford University Press, Oxford.
51. Ratcliffe J. The use of conjoint analysis to elicit willingness-to-pay values. International Journal of Technology Assessment in Health Care 2000, 16(1):270-290.
52. Ryan M., Gerard K., Currie G. Using discrete choice experiments in health economics. The Elgar companion to health economics 2006, 405-414. Edward Elgar Publishing Limited, Cheltenham. A. Jones (Ed.).
53. National Institute for Health and Clinical Excellence Guide to the methods of technology appraisal 2008, NICE, London.
54. Claxton K., et al. Appropriate Perspectives for Health Care Decisions, in CHE Research Paper 54 2010, The University of York, Centre for Health Economics, York.
55. Pharmaceutical Benefits Advisory Committee Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee (Version 4.3) 2008, Australian Government, Department of Health and Ageing, Canberra.
56. HM Treasury The green book: appraisal and evaluation in central government 2003, TSO, London.
57. Office of Best Practice Regulation (OBPR) Best practice regulation handbook 2007, Australian Government, Canberra.
58. Lancaster K.J. A new approach to consumer theory. Journal of Political Economy 1966, 74(2):132.
59. Ryan M., Gerard K. Using discrete choice experiments to value health care programmes: current practice and future research reflections. Applied Health Economics and Health Policy 2003, 2(1):55-64.
60. Lancsar E., Savage E. Deriving welfare measures from discrete choice experiments: inconsistency between current methods and random utility and welfare theory. Health Economics 2004, 13:901-907.
61. Mark T., Swait J. Using stated preference and revealed preference modeling to evaluate prescribing decisions. Health Economics 2004, 13:563-573.
62. Baker R., et al. Weighting and valuing quality adjusted life years: preliminary results from the Social Value of a QALY Project 2008, Institute of Health and Society, Newcastle University, Newcastle.
63. Grutters J., et al. Willingness to accept versus willingness to pay in a discrete choice experiment. Value in Health 2008, 11(7):1110-1119.
64. Boughton B.J. Compulsory health and safety in a free society. Journal of Medical Ethics 1984, 10(4):186-190.
65. Wallace N. Health department bans staff smoke breaks 2010, Sydney Morning Herald, Sydney.